Matches 1 - 50 out of 89 1 2 >


Match Document Document Title
US20140024590 KRAS-Variant And Endometriosis  
The invention provides methods for predicting an increased risk or probability of developing endometriosis in a patient based upon the patient's KRAS variant status.
US20130288967 MATERIALS AND METHODS FOR CANCER DIAGNOSIS BY EVALUATION OF THE METHYLATION STATUS OF CPG ISLANDS ON CHROMOSOMES 6 AND 8  
Provided are methods, reagents, and kits for evaluating cancer, such as prostate cancer, in a subject. Disclosed methods of evaluating cancer include methods of diagnosing cancer, methods of...
US20100297105 ADMINISTERING ANTISENSE OLIGONUCLEOTIDES COMPLEMENTARY TO HUMAN APOLIPOPROTEIN B  
Methods for long-term lowering of lipid levels in human subjects and for the treatment of conditions associated with elevated LDL-cholesterol and elevated ApoB are provided.
US20150065426 Testosterone Booster Transdermal Compositions  
Formulations and methods for transdermal drug delivery compositions that include synergistic combination of three pharmaceutical active ingredients (APIs), such as testosterone, anastrozole, and...
US20070123461 Reproductive management  
A method for breeding, especially a method for breeding dairy cattle without use of heat detection prior to insemination.
US20150111825 OSTEOCALCIN AS A TREATMENT FOR MALE REPRODUCTIVE DISORDERS  
Methods and compositions for treating, preventing, or diagnosing disorders related to reproduction in male mammals, preferably humans, are provided. The methods generally involve modulation of the...
US20050245439 Prevention of joint destruction  
A method for treating, preventing or reducing the risk of joint destruction in a subject who suffers from a joint or musculoskeletal disease. The method comprises administering a histone...
US20130064821 METHODS AND COMPOSITIONS FOR TREATING PROSTATE CANCER  
A polypeptide comprising an androgen binding region, the androgen binding region capable of binding to an androgen at a sufficient affinity or avidity such that upon administration of the...
US20080032935 APPLICATION OF INITIAL DOSES OF LHRH ANALOGUES AND MAINTENANCE DOSES OF LHRH ANTAGONISTS FOR THE TREATMENT OF HORMONE-DEPENDENT CANCERS AND CORRESPONDING PHARMACEUTICAL KITS  
LHRH analogues and LHRH antagonists for use in the treatment or prophylaxis of hormone-dependent cancers, in particular prostate cancer, prostate carcinoma and/or advanced prostate carcinoma, by...
US20120071401 AMYLIN AGONIST COMPOUNDS FOR ESTROGEN-DEFICIENT MAMMALS  
Provided herein are methods to treat estrogen deficiency in mammals by administering amylin agonist compounds. Also provided herein are methods to treat obesity and overweight in...
US20060270591 Androgen receptor coregulators  
Disclosed are compositions and methods related to androgen receptor coregulators.
US20050288230 Non-steroidal anti-androgen therapy  
The present invention relates to a method of enhancing bone mineral density (BMD) in a patient in need thereof by administration of an effective amount of a non-steroidal anti-androgen compound,...
US20070173434 Antidiabetic oxazolidinediones and thiazolidinediones  
Phenoxyphenyl and phenoxybenzyl oxazolidine-2,4-diones and thiazolidine-2,4-diones of formula (I) are agonists or partial agonists of PPAR gamma and are useful in the treatment and control of...
US20060094660 Inhibitor of the shh signalling patway and a testosterone supressing agent for the treatment of cancer  
A method of protecting a patient from possible adverse effects of a treatment involving inhibition of the SHH-signalling pathway in the patient, the method comprising suppressing testosterone or...
US20120121602 NOVEL PROTEINS  
Provided herein are four polypeptides, named PRT5, PRT6, PRT7 and PRT8, the nucleic acids encoding the same, compositions comprising the proteins, as well as their uses in therapeutic and...
US20070066532 Compositions and methods for treatment of muscle pain and muscle wasting  
Compositions and methods for alleviating the symptoms associated with muscle pain in general or muscle wasting are provided. The compositions are based on use of androgens, either alone or in...
US20050245456 Combination therapy to prevent and treat diarrhea induced by cancer treatment  
This invention relates to a method of treating drug side effects in cancer treatment. More particularly, the present invention relates to preventing, reducing, alleviating, or reversing diarrhea...
US20070275036 AVIAN FOLLISTATIN PRODUCT  
Described herein are avian follistatin products, and methods for producing such products, in which such products are effective for a variety of conditions, including increasing muscle mass. Avian...
US20080069791 Means for stimulation and activation of hair growth by il-15  
The present invention relates to the use of IL-15 polynucleotides, polypeptides or compounds which bind to an antibody which specifically recognizes the IL-15 polypeptide or which specifically...
US20060035813 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors  
Novel compounds, pharmaceutical compositions, and methods are provided for modulating processes mediated by nuclear hormone receptors. A partial or complete agonist or antagonist modulates,...
US20070275904 CONJUGATES OF AZIRIDINYL-EPOTHILONE ANALOGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAME  
The present invention is directed to conjugated compounds comprising a folate, or an analog or derivative thereof, and an aziridinyl epothilone analog, as further described herein, and/or...
US20070232528 Formulation comprising histone deacetylase inhibitors  
The present invention relates to an orally available galenics formulation of Valproic Acid or derivatives thereof exhibiting a specific bi-phasic pharmacokinetic profile optimized for maximum...
US20050037089 Method for promoting bone growth  
A method for treating a patient to promote bone growth, comprising: administering to the patient a therapeutic amount of a bone remodeling agent effective to stimulate bone growth, and a dietary...
US20070173447 METHOD FOR TREATING OSTEOPOROSIS BY INTRANASAL DELIVERY OF TERIPARATIDE WITH AN ANTI-RESORPTIVE AGENT  
A method for treating osteoporosis in a mammal by administering intranasally a therapeutically effective amount of a PTH formulation to the mammal in combination with administration of an...
US20080025972 Treating sex steriod responsive disorders  
Sex steroid potentiated disorders including, prostate cancer and breast cancer, in a patient in need of treatment thereof, are treated with an amount of nitric oxide donating compound and/or...
US20080182775 Nonhuman animal reproducing pathogenic conditions of spinal and bulbar muscular atrophy and remedy for spinal and bulbar muscular atrophy  
It is intended to provide a model animal faithfully reproducing the pathogenic conditions of spinal and bulbar muscular atrophy, a method of screening a remedy for polyglutamine disease using the...
US20070202091 Nutraceutical composition and method for promoting the rejuvenation of cells in warm-blooded animals including humans  
A nutraceutical composition and method for promoting the rejuvenation of cells in warm-blooded animals including humans employing mitochondrial energy production-inducing agent for inducing the...
US20060183744 Method for treating depression and/or anxiety  
This invention relates to the treatment and/or prevention of depression and/or anxiety disorders and/or dementia by the administration of an estrogen receptor beta (ERβ) selective agonist either...
US20060019883 Use of cyclin D1 inhibitors  
The present invention relates to use of certain cyclin D1 inhibitors at the manufacture of pharmaceutical preparations to be used in the treatment of patients to improve their response to...
US20060088899 Combination chemotherapy with chlorotoxin  
This invention includes compositions and methods for combination chemotherapy, particularly involving at least one chemotherapeutic agent used in combination with chlorotoxin or a derivative thereof.
US20070078091 Pharmaceutical combinations for compensating for a testosterone deficiency in men while simultaneously protecting the prostate  
This invention relates to pharmaceutical combinations for compensating for an absolute and relative testosterone deficiency in men with simultaneous prophylaxis for the development of a benign...
US20100291086 USE OF ESTROGEN AND ANDROGEN BINDING PROTEINS IN METHODS AND COMPOSITIONS FOR TREATING GYNAECOLOGICAL CANCERS  
The present invention provides a polypeptide comprising an estrogen or androgen binding region, the binding region capable of binding to an estrogen or androgen at a sufficient affinity or avidity...
US20050095241 Estrogen receptor modulators and uses thereof  
The present disclosure relates to the field of cellular tumorigenesis and cancer biology. More specifically, the present disclosure relates to tumorigenesis and cancer in estrogen-responsive cell...
US20060216295 Methods of identifying therapeutic targets for the treatment of vulvovaginal atrophy  
Disclosed herein are methods for the identification of effector molecules useful in the treatment of vulvovaginal atrophy. Methods of treating vulvovaginal atrophy comprising administering the...
US20060040855 Low efficacy gonadotropin agonists and antagonists  
The present invention provides glycoprotein hormone analogs having partial agonist/antagonist activity comprising an α-subunit polypeptide and a β-subunit polypeptide. The analog lacks a naturally...
US20060127412 Aromatase activator  
Drugs and cosmetics which are highly safe, and which are effective in preventing, improving, or treating various pathological conditions caused by estrogen depletion are provided. Provided are...
US20050215499 Lipoproteins as nucleic acid vectors  
The present invention relates to materials and methods for the in vivo transport and deliver of nucleic acids. More particularly, it concerns the use of lipoproteins, including but not limited to,...
US20080051342 TRPS1-mediated modulation of hair growth  
The present invention provides for methods of inhibiting hair growth, comprising decreasing the level of TRPS1 mRNA and/or protein in hair follicle cells of a subject. The present invention also...
US20050095245 Pharmaceutical delivery system  
A pharmaceutical formulation to treat vaginal conditions in a human patient comprises: at least one active agent; a modified release dosage form which provides extended release of the...
US20070054859 Estrogen receptor-related receptor alpha (ERRalpha) and cartilage formation  
Estrogen related receptor α (ERRα) is involved in control of cartilage formation in mammals. Increasing ERRα activity causes stimulation of cartilage formation, providing a means of therapeutic...
US20060193844 Methods for enzyme inhibition  
Improved regimens for administering proteasome inhibitors are described, wherein proteasome inhibition is more sustained relative to certain current regimens which permit substantial recovery of...
US20070065498 Encapsulated arsenic drugs  
The present invention relates to methods and compositions for the treatment of cancer and for research and analysis of cancer. In particular, the present invention provides encapsulated arsenic...
US20050233970 Methods for treating long QT syndrome  
The present invention provides compositions and methods for treating QT prolongation in a subject in need thereof. The method comprises the step of administering to the subject a therapeutically...
US20060034847 Methods of treating a subject for a condition  
Methods are provided for treating a subject for at least one condition that includes inflammation, a blood clotting condition and autonomic nervous system dysfunction such as adrenergia, e.g.,...
US20050256048 Selective androgen receptor modulators and methods for their identification, design and use  
Selective androgen receptor modulators (SARMs) having antagonist activity in hormone-dependent tumors while exhibiting no activity or agonist activity against other nontumor tissues containing the...
US20070244039 Therapeutic agent composition and method of use  
The invention relates to the use of cyclic Prolyl Glycine (“cyclic PG” or “cPG”) and analogs and mimetics thereof, as neuroprotective agents for the treatment and or prevention of neurological...
US20080108574 MELANOCORTIN RECEPTOR MEDIATED MODULATION OF NEUROGENESIS  
The present disclosure describes compositions and methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The...
US20110300150 COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE AND OTHER DISEASE  
Provided are methods relating to the use of CDP-therapeutic agent conjugates for the treatment of autoimmune disease, inflammatory disease, or cancer. Also provided are CDP-therapeutic agent...
US20070254314 Methods of treating autism and autism spectrum disorders  
The present invention relates to methods of treating a subject diagnosed with autism or an autism spectrum disorder, lowering the level of mercury in a subject determined to contain a high level...
US20070190080 Non-aqueous compositions for oral delivery of insoluble bioactive agents  
The present invention provides a composition of low water solubility drug, dissolved or dispersed in a non crystalline or low crystalline form in an emulsion type composition of internal...

Matches 1 - 50 out of 89 1 2 >